William J. Greenlee;Eric J. Gilbert;Michael W. Miller;Andrew W. Stamford
发明人:
Eric J. Gilbert,Michael W. Miller,Andrew W. Stamford,William J. Greenlee
申请号：
US13377707
公开号：
US20120108505A1
申请日:
2010.06.10
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The present invention relates to compounds of the general formula (I): wherein R1, R2, R3, R5, s, and Z are selected independently of each other and are as defined herein, to compositions comprising the compounds, and methods of using the compounds as glucagon receptor antagonists and for the treatment or prevention of type 2 diabetes and conditions related thereto.
